Skip to main content
SpringerLink
Log in
Book cover

Fibrocystic Diseases of the Liver pp 331–358Cite as

Caroli Disease, Caroli Syndrome, and Congenital Hepatic Fibrosis

  • Chapter
  • First Online:

Part of the book series: Clinical Gastroenterology ((CG))

Summary

The cystic diseases of the liver are mostly autosomal recessive disorders with variable intrahepatic biliary dilatation and increased hepatic fibrosis either as part of the underlying defect or as a result of liver damage from recurrent episodes of ascending cholangitis. Caroli disease (CD) denotes congenital saccular intrahepatic dilatation of the biliary tree. Caroli syndrome (CS) is a more common disorder in which the bile duct dilatation is associated with congenital hepatic fibrosis (CHF). The clinical manifestations of CS are related to the biliary abnormalities and portal hypertension. Recurrent bacterial cholangitis, liver abscesses, intra- and extrahepatic stones, and increased risk of cholangiocarcinoma are the main complications of CD and CS. Treatment is supportive and directed toward treating the biliary tract infections and the complications of portal hypertension. Surgical treatment consists of liver resection or liver transplantation. The prognosis of CD and CS is variable depending on the severity of the disease, the presence of portal hypertension, and the presence of coexisting renal disease.

CHF is a hereditary developmental malformation that belongs to the family of hepatic ductal plate malformation (DPM), which resulted from persistence of excess embryonic bile duct structures in the portal tracts. It may be associated with other liver malformations such as in CS and it is usually associated with autosomal recessive polycystic kidney disease (ARPKD). The identification of the gene for ARPKD, PKHD1 (polycystic kidney and hepatic disease 1) had shown that most cases of ARPKD with CHF are genetically homogeneous. Clinically, symptoms vary and different manifestations of CHF have been described such as portal hypertensive CHF, cholangitic CHF, combined portal hypertensive and cholangitic CHF, and latent forms of CHF. Therapy of CHF depends on the clinical manifestation of the disease. Treatment is largely supportive and it is directed toward treating biliary tract infection and the complications of portal hypertension. Liver transplantation is indicated in patients with recurrent uncontrolled cholangitis and in patients with end-stage liver disease.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Kerkar N, Norton K, Suchy FJ. The hepatic fibrocystic diseases. Clin Liver Dis 2006;10, 55–71.

    Article  PubMed  Google Scholar 

  2. Caroli J, Soupault R, Kossakowski J, Plocker L. Congenital polycystic dilation of the intrahepatic bile ducts, attempt at classification. Sem Hop 1958;34, 488–495.

    CAS  PubMed  Google Scholar 

  3. Desmet VJ. What is congenital hepatic fibrosis? Histopathology 1992;20, 465–477.

    Article  CAS  PubMed  Google Scholar 

  4. Desmet VJ. Ludwig symposium on biliary disorders – part I. Pathogenesis of ductal plate abnormalities. Mayo Clin Proc 1998;73, 80–89.

    Article  CAS  PubMed  Google Scholar 

  5. Yönem O, Ozkayar N, Balkanci F et al. Is congenital hepatic fibrosis a pure liver disease? Am J Gastroenterol 2006;101, 1253–1259.

    Article  PubMed  Google Scholar 

  6. Bernstein J, Slovis TL. Polycystic disease of the kidney. In Edelmann CM Jr., (ed) Pediatric Kidney Disease, 1992. Boston: Little Brown, 1139–1153.

    Google Scholar 

  7. Jordan D, Harpaz N, Thung SN. Caroli’s disease and adult polycystic kidney disease: A rare recognized association. Liver 1989;9, 30–35.

    Google Scholar 

  8. Torra R, Badenas C, Darnell A et al. Autosomal dominant polycystic kidney disease with anticipation and Caroli’s disease associated with a PKD1 mutation. Rapid communication. Kidney Int 1 1997;52, 33–38.

    Article  CAS  Google Scholar 

  9. Summerfield JA, Nagafuchi Y, Sherlock S et al. Hepatobiliary fibropolycystic diseases. A clinical and histological review of 51 patients. J Hepatol 1986;2, 141–156.

    Article  CAS  PubMed  Google Scholar 

  10. Erlinger S. Cystic dilatation of the biliary tract. Rev Prat 2000;50, 2136–2141.

    CAS  PubMed  Google Scholar 

  11. Haruta I, Shindou H, Hayashi N et al. Two cases in siblings of congenital multiple cystic dilatation of peripheral intrahepatic bile ducts (so-called Caroli’s disease). Jpn J Gastroenterol 1989;86, 1338–1339.

    Google Scholar 

  12. Hoglund M, Muren C, Schmidt D. Caroli’s disease in two sisters. Acta Radiologica 1989;30, 459–462.

    Article  CAS  PubMed  Google Scholar 

  13. Kim MH, Ryu JS, Yang SK et al. Three cases of congenital hepatic fibrosis with Caroli’s disease in three siblings. Korean J Int Med 1990;5, 101–107.

    CAS  Google Scholar 

  14. Yoshizawa K, Kiyosawa K, Yabu K et al. Caroli’s disease in three siblings. Gastroenterologia Japonica 1992;27, 780–784.

    CAS  PubMed  Google Scholar 

  15. Wu KL, Changchien CS, Kuo CM et al. Caroli’s disease – a report of two siblings. Eur J Gastroenterol Hepatol 2002;14, 1397–1399.

    Article  PubMed  Google Scholar 

  16. Tsuchida Y, Sato T, Sanjo K et al. Evaluation of long-term results of Caroli’s disease: 21 years’ observation of a family with autosomal “dominant” inheritance and review of the literature. Hepatogastroenterology 1995;42, 175–181.

    CAS  PubMed  Google Scholar 

  17. Taylor AC, Palmer KR. Caroli’s disease. Eur J Gastroenterol Hepatol 1998;10, 105–108.

    Article  CAS  PubMed  Google Scholar 

  18. Lu SC, Debian KA. Cystic diseases of the biliary tract. In Yamada T, Alpers DH, Kaplowitz N, Laine L, Owyang C, Powell DW, (eds) Textbook of Gastroenterology, 2003. Philadelphia: Lippincott Williams and Wilkins, 2225–2235.

    Google Scholar 

  19. Awasthi A, Das A, Srinivasan R, Joshi K. Morphological and immunohistochemical analysis of ductal plate malformation: Correlation with fetal liver. Histopathology 2004;45, 260–267.

    Article  CAS  PubMed  Google Scholar 

  20. Roskams T, Desmet V. Embryology of extra- and intra-hepatic bile ducts, the ductal plate. Anat Rec (Hoboken) 2008;291(6), 628–635.

    CAS  Google Scholar 

  21. Lina F, Satlinb LM. Polycystic kidney disease: The cilium as a common pathway in cystogenesis. Curr Opin Pediatr 2004;16, 171– 176.

    Article  PubMed  Google Scholar 

  22. Ward CJ, Hogan MC, Rossetti S et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet 2002;30, 259–269.

    Article  PubMed  Google Scholar 

  23. Al-Bhalal L, Akhtar M. Molecular basis of autosomal recessive polycystic kidney disease (ARPKD). Adv Anat Pathol 2008;15(1), 54–58.

    Article  CAS  PubMed  Google Scholar 

  24. Desmet VJ. Congenital diseases of intrahepatic bile ducts: Variations on the theme “ductal plate malformation”. Hepatology 1992;16, 1069–1083.

    Article  CAS  PubMed  Google Scholar 

  25. D’Agata ID, Jonas MM, Perez-Atayde AR, Guay-Woodford LM. Combined cystic disease of the liver and kidney. Semin Liver Dis 1994;4, 215–228.

    Article  Google Scholar 

  26. Gillet M, Favre S, Fontolliet C et al. Monolobar Caroli’s disease. Apropos of 12 cases. Chirurgie 1999;124(1), 13–18, discussion 18–19.

    Article  CAS  PubMed  Google Scholar 

  27. Murray-Lyon IM, Shilkin KB, Laws JW et al. Non-obstructive dilatation of the intrahepatic biliary tree with cholangitis. Q J Med 1972;41, 477–489.

    CAS  PubMed  Google Scholar 

  28. Giovanardi RO. Monolobar Caroli’s disease in an adult. Case report. Hepatogastroenterology 2003;50(54), 2185–2187.

    PubMed  Google Scholar 

  29. Yonem O, Bayraktar Y. Clinical characteristics of Caroli’s disease. World J Gastroenterol 2007;13, 1930–1933.

    PubMed  Google Scholar 

  30. Kassahun WT, Kahn T, Wittekind C et al. Caroli’s disease: Liver resection and liver transplantation. Experience in 33 patients. Surgery 2005;138(5), 888–898.

    Article  PubMed  Google Scholar 

  31. Dağli U, Atalay F, Saşmaz N et al. Caroli’s disease: 1977–1995 experiences. Eur J Gastroenterol Hepatol 1998;10, 109– 112.

    Article  PubMed  Google Scholar 

  32. Pinto RB, Lima JP, da Silveira TR et al. Caroli’s disease: Report of 10 cases in children and adolescents in southern Brazil. J Pediatr Surg 1998;33(10), 1531–1535.

    Google Scholar 

  33. Luciani A, Kobeiter H, Zegai B et al. Imaging in congenital fibrocystic diseases of the liver. Gastroenterol Clin Biol 2005;29(8–9), 870–874.

    Article  PubMed  Google Scholar 

  34. Levy AD, Rohrmann CA, Jr, Murakata LA, Lonergan GJ. Caroli’s disease: Radiologic spectrum with pathologic correlation. Am J Roentgenol 2002;179, 1053–1057.

    Google Scholar 

  35. Pavone P, Laghi A, Catalano C et al. Caroli’s disease: Evaluation with MR cholangiopancreatography (MRCP). Abdom Imaging 1996;21, 117–119.

    Article  CAS  PubMed  Google Scholar 

  36. Guy F, Cognet F, Dranssart M et al. Caroli’s disease: Magnetic resonance imaging features. Eur Radiol 2002;12, 2730–2736.

    PubMed  Google Scholar 

  37. Park DH, Kim MH, Lee SK et al. Can MRCP replace the diagnostic role of ERCP for patients with choledochal cysts? Gastrointest Endosc 2005;62, 360–366.

    Article  PubMed  Google Scholar 

  38. Krausé D, Cercueil JP, Dranssart M et al. MRI for evaluating congenital bile duct abnormalities. J Comput Assist Tomogr 2002;26, 541–552.

    Article  PubMed  Google Scholar 

  39. Goilav B, Norton KI, Satlin LM et al. Predominant extrahepatic biliary disease in autosomal recessive polycystic kidney disease: A new association. Pediatr Transplant 2006;10, 294–298.

    Article  PubMed  Google Scholar 

  40. Yonem O, Bayraktar Y. Clinical characteristics of Caroli’s syndrome. World J Gastroenterol 2007;13, 1934–1937.

    PubMed  Google Scholar 

  41. Tsuchiya R, Nishimura R, Ito T. Congenital cystic dilation of the bile duct associated with Laurence-Moon-Biedl-Bardet syndrome. Arch Surg 1977;112, 82–84.

    CAS  PubMed  Google Scholar 

  42. Totkas S, Hohenberger P. Cholangiocellular carcinoma associated with segmental Caroli’s disease. Eur J Surg Oncol 2000;26, 520–521.

    Article  CAS  PubMed  Google Scholar 

  43. Kasper HU, Stippel DL, Töx U et al. Primary cholangiocarcinoma in a case of Caroli’s disease: Case report and literature review. Pathologe 2006;27, 300–304.

    Google Scholar 

  44. Dayton MT, Longmire WP, Jr, Tompkins RK. Caroli’s disease: A premalignant condition? Am J Surg 1983;145, 41–48.

    Article  CAS  PubMed  Google Scholar 

  45. Mazigh MS, Aloui N, Fetni I et al. Congenital hepatic fibrosis in children. Report of 9 cases and review of the literature. Tunis Med 2006;84, 182–188.

    Google Scholar 

  46. Etienne JC, Bouillot JL, Alexandre JH. Cholangiocarcinoma associated with Caroli’s disease. Apropos of a case. Review of the literature. J Chir (paris) 1987;124, 161–164.

    CAS  Google Scholar 

  47. Lowenfels A. Does bile promote extracolonic cancer? Lancet 1978;2, 239–241.

    Article  CAS  PubMed  Google Scholar 

  48. Waechter FL, Sampaio JA, Pinto RD et al. The role of liver transplantation in patients with Caroli’s disease. Hepatogastroenterology 2001;48, 672–674.

    CAS  PubMed  Google Scholar 

  49. Fevery J, Tanghe W, Kerremans R et al. Congenital dilatation of the intrahepatic bile ducts associated with the development of amyloidosis. Gut 1972;13, 604–609.

    Article  CAS  PubMed  Google Scholar 

  50. Fagundes ED, Ferreira AR, Roquete ML et al. Clinical and laboratory predictors of esophageal varices in children and adolescents with portal hypertension syndrome. J Pediatr Gastroenterol Nutr 2008;46, 178–183.

    Article  PubMed  Google Scholar 

  51. Ulrich F, Pratschke J, Pascher A et al. Long-term outcome of liver resection and transplantation for Caroli disease and syndrome. Ann Surg 2008;247, 357–364.

    Article  PubMed  Google Scholar 

  52. Bockhorn M, Malagó M, Lang H et al. The role of surgery in Caroli’s disease. J Am Coll Surg 2006;202, 928–932.

    Article  PubMed  Google Scholar 

  53. Shneider BL, Magid MS. Liver disease in autosomal recessive polycystic kidney disease. Pediatr Transplant 2005;9, 634–639.

    Article  PubMed  Google Scholar 

  54. Millwala F, Segev DL, Thuluvath PJ. Caroli’s disease and outcomes after liver transplantation. Liver Transpl 2008;14, 11–17.

    Article  PubMed  Google Scholar 

  55. Habib S, Shaikh OS. Caroli’s disease and liver transplantation. Liver Transpl 2008;14, 2–3.

    Article  PubMed  Google Scholar 

  56. Poddar U, Thapa BR, Vashishta RK et al. Congenital hepatic fibrosis in Indian children. J Gastroenterol Hepatol 1999;14, 1192–1196.

    Article  CAS  PubMed  Google Scholar 

  57. Kerr DNS, Harrison CV, Sherlock S, Walker RM. Congenital hepatic fibrosis. Q J Med 1961;30, 91–117.

    CAS  PubMed  Google Scholar 

  58. Averback P. Congenital hepatic fibrosis: Asymptomatic adults without renal anomaly. Arch Pathol Lab Med 1977;101, 260–261.

    CAS  PubMed  Google Scholar 

  59. Tazelaar HD, Payne JA, Patel NS. Congenital hepatic fibrosis and asymptomatic familial adult-type polycystic kidney disease in a 19-year-old woman. Gastroenterology 1984;86, 757–760.

    CAS  PubMed  Google Scholar 

  60. Lipschitz B, Berdon WE, Defelice AR, Levy J. Association of congenital hepatic fibrosis with autosomal dominant polycystic kidney disease. Report of a family with review of literature. Pediatr Radiol 1993;23, 131–133.

    Google Scholar 

  61. Witzleben CL, Sharp AR. “Nephronophthisis-congenital hepatic fibrosis”: An additional hepatorenal disorder. Hum Pathol 1982;13, 728–733.

    Article  CAS  PubMed  Google Scholar 

  62. Harris HW, Jr, Carpenter TO, Shanley P, Rosen S et al. Progressive tubulointerstitial renal disease in infancy with associated hepatic abnormalities. Am J Med 1986;81, 169–176.

    Article  PubMed  Google Scholar 

  63. Capisonda R, Phan V, Traubuci J et al. Autosomal recessive polycystic kidney disease: Outcomes from a single-center experience. Pediatr Nephrol 2003;18, 119–126.

    PubMed  Google Scholar 

  64. Guay-Woodford LM, Desmond RA. Autosomal recessive polycystic kidney disease: The clinical experience in North America. Pediatrics 2003;111, 1072–1080.

    Article  PubMed  Google Scholar 

  65. Bergmann C, Senderek J, Windelen E et al. Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD). Kidney Int 2005;67, 829– 848.

    Article  CAS  PubMed  Google Scholar 

  66. Khan K, Schwarzenberg SJ, Sharp HL et al. Morbidity from congenital hepatic fibrosis after renal transplantation for autosomal recessive polycystic kidney disease. Am J Transplant 2002;2, 360–365.

    Article  PubMed  Google Scholar 

  67. Blyth H, Ockenden BG. Polycystic kidney disease of the kidneys and liver presenting in childhood. J Med Genet 1971;8, 257–284.

    Article  CAS  PubMed  Google Scholar 

  68. Gunay-Aygun M, Avner ED, Bacallao RL et al. Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: Summary statement of a first National Institutes of Health/Office of Rare Diseases conference. J Pediatr 2006;149, 159–164.

    Article  PubMed  Google Scholar 

  69. Whitley CB, Schwarzenberg SJ, Burke BA et al. Direct hypebilirubinemia and hepatic fibrosis: A new presentation of Jeune syndrome (asphyxiating thoracic dystrophy). Am J med Genet suppl 1987;3, 211–220.

    Article  CAS  PubMed  Google Scholar 

  70. Lewis SM, Roberts EA, Marcon MA et al. Joubert’s syndrome with congenital hepatic fibrosis: An entity in the spectrum of oculo-encephalo-hepato-renal disorders. Am J med Genet 1994;52, 419–426.

    Article  CAS  PubMed  Google Scholar 

  71. Verloes A, Lambotte C. Further delineation of a syndrome of cerebellar vermis hypo/aplasia, oligophrenia, congenital ataxia, coloboma, and hepatic fibrosis. Am J med Genet 1989;32, 227–232.

    Article  CAS  PubMed  Google Scholar 

  72. Esmer C, Alvarez-Mendoza A, Lieberman E et al. Liver fibrocystic disease and polydactyly: Proposal of a new syndrome. Am J Med Genet 2001;101, 12–16.

    Article  CAS  PubMed  Google Scholar 

  73. Vankalakunti M, Gupta K, Kakkar N, Das A. Renal-hepatic-pancreatic dysplasia syndrome (Ivemark’s syndrome). Diagn Pathol 2007;2, 24.

    Article  PubMed  Google Scholar 

  74. Freeze HH. Congenital disorders of glycosylation and the pediatric liver. Semin Liver Dis 2001;21, 501–515.

    Article  CAS  PubMed  Google Scholar 

  75. Yönem O, Ozkayar N, Balkanci F et al. Is congenital hepatic fibrosis a pure liver disease? Am J Gastroenterol 2006;101, 1253–1259.

    Article  PubMed  Google Scholar 

  76. Sedlaczek N, Jia JD, Bauer M et al. Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. Am J Pathol 2001;158, 1239–1244.

    CAS  PubMed  Google Scholar 

  77. Sato Y, Harada K, Kizawa K et al. Activation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli’s disease. Am J Pathol 2005;166, 49–60.

    CAS  PubMed  Google Scholar 

  78. Frazier K, Williams S, Kothapalli D et al. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996;107, 404–411.

    Article  CAS  PubMed  Google Scholar 

  79. Paradis V, Dargere D, Bonvoust F et al. Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab Invest 2002;82, 767–774.

    CAS  PubMed  Google Scholar 

  80. Hacker U, Nybakken K, Perrimon N. Heparan sulphate proteoglycans: The sweet side of development. Nat Rev Mol Cell Biol 2005;6, 530–541.

    Article  PubMed  Google Scholar 

  81. Ozaki S, Sato Y, Yasoshima M et al. Diffuse expression of heparan sulfate proteoglycan and connective tissue growth factor in fibrous septa with many mast cells relate to unresolving hepatic fibrosis of congenital hepatic fibrosis. Liver Int 2005;25, 817–828.

    Article  CAS  PubMed  Google Scholar 

  82. Scheuer PJ, Lefkowitch JH. Liver Biopsy Interpretation Fifth Edition, Volume 31 in the Series Major Problems in Pathology, 1994. Philadelphia: W. B. Saunders Company, 201–202.

    Google Scholar 

  83. Gang DL, Herrin JT. Infantile polycystic disease of the liver and kidneys. Clin Nephrol 1986;25, 28–36.

    CAS  PubMed  Google Scholar 

  84. Zeitoun D, Brancatelli G, Colombat M et al. Congenital hepatic fibrosis: CT findings in 18 adults. Radiology 2004;231, 109–116.

    Article  PubMed  Google Scholar 

  85. Murray-Lyon I, Ockenden B, Williams R. Congenital hepatic fibrosis-is it a single clinical entity? Gatroenterology 1978;64, 653–656.

    Google Scholar 

  86. Fiorillo A, Migilioati R, Vajro P et al. Congenital hepatic fibrosis with gastrointestinal bleeding in early infancy. Clinical Pediatrics 1982;21, 183–184.

    Article  CAS  PubMed  Google Scholar 

  87. Alvarez F, Bernard O, Brunelle F et al. Congenital hepatic Fibrosis in children. J Pediatr 1981;99, 370–375.

    Article  CAS  PubMed  Google Scholar 

  88. Kaariainen H, Koskimies O, Norio R. Dominant and recessive polycystic kidney disease in children: Evaluation of clinical features and laboratory data. Pediatr Nephrol 1988;2, 296–302.

    Article  CAS  PubMed  Google Scholar 

  89. Zerres K, Rudnik-Schöneborn S, Deget F et al. Autosomal recessive polycystic kidney disease in 115 children: Clinical course and influence of gender. Acta Pediatr 1996;85, 437–445.

    Article  CAS  Google Scholar 

  90. Cole BR, Conley SB, Stapleton B. Polycystic kidney disease in the first year of life. J Pediatr 1987;111, 693–699.

    Article  CAS  PubMed  Google Scholar 

  91. Davis ID, Ho M, Hupertz V, Avner ED. Survival of childhood polycystic kidney disease following renal transplantation: The impact of advanced hepatobiliary disease. Pediatr Transplant 2003;7, 364–369.

    Article  PubMed  Google Scholar 

  92. Consugar MB, Anderson SA, Rossetti S et al. Haplotype analysis improves molecular diagnostics of autosomal recessive polycystic kidney disease. Am J Kidney Dis 2005;45, 77–87.

    Article  CAS  PubMed  Google Scholar 

  93. Zerres K, Senderek J, Rudnik-Schöneborn S et al. New options for prenatal diagnosis in autosomal recessive polycystic kidney disease by mutation analysis of the PKHD1 gene. Clin Genet 2004;66, 53–57.

    Article  CAS  PubMed  Google Scholar 

  94. Akhan O, Karaosmanoğlu AD, Ergen B. Imaging findings in congenital hepatic fibrosis. Eur J Radiol 2007;61, 18–24.

    Article  PubMed  Google Scholar 

  95. Zerres K, Rudnick-Schoneborn S, Steinkamm C et al. Autosomal recessive polycystic kidney disease. J Mol Med 1998;7, 303–309.

    Article  Google Scholar 

  96. Shneider BL. Portal hypertension. In Suchy F, Sokol R, Balistreri W, eds. Liver Disease in Children, 2001. Philadelphia: Lippincott Williams & Wilkins, 129–151.

    Google Scholar 

  97. Moon SB, Jung SE, Ha JW et al. The usefulness of distal splenorenal shunt in children with portal hypertension for the treatment of severe thrombocytopenia and leukopenia. World J Surg 2008;32, 483–487.

    Article  PubMed  Google Scholar 

  98. Nagral A, Nabi F, Humar A et al. Reversal of severe hepato-pulmonary syndrome in congenital hepatic fibrosis after living-related liver transplantation. Indian J Gastroenterol 2007;26, 88–89.

    PubMed  Google Scholar 

  99. Kerr DNS, Okonkwo S, Choa RG. Congenital hepatic fibrosis: The long term prognosis. Gut 1978;19, 514–520.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

The authors thank Ally Rosen, MD for her assistance in selecting the MRI images.

Author information

Authors and Affiliations

  1. Department of Pediatrics and RMTI, Mt. Sinai Medical Center, New York, NY, USA

    Ronen Arnon MD

  2. Department of Radiology, Mount Sinai Medical Center, Mount Sinai School of Medicine, New York, NY, USA

    Henrietta Kotlus Rosenberg MD, FACR, FAAP

  3. Jack and Lucy Clark Department of Pediatrics, Mount Sinai Kravis Children’s Hospital, Mount Sinai School of Medicine of New York University, New York, NY, USA

    Frederick J. Suchy MD

Authors
  1. Ronen Arnon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Henrietta Kotlus Rosenberg MD, FACR, FAAP
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Frederick J. Suchy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. School of Medicine, Children's Hospital & Regional, University of Washington, Sand Point Way NE. 4800, Seattle, 98105, USA

    Karen F. Murray

  2. St. Paul University Hospital, Harry Hines Blvd. 5939, Dallas, 75390-9258, USA

    Anne M. Larson

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Arnon, R., Rosenberg, H.K., Suchy, F.J. (2010). Caroli Disease, Caroli Syndrome, and Congenital Hepatic Fibrosis. In: Murray, K., Larson, A. (eds) Fibrocystic Diseases of the Liver. Clinical Gastroenterology. Humana Press. https://doi.org/10.1007/978-1-60327-524-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-524-8_14

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-523-1

  • Online ISBN: 978-1-60327-524-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation